Showing results (881-890 of 967) with videos related to
Sort By:
Pageof 97
Hepatology Research : the Official Journal of the Japan Society of Hepatology|December 3, 2020
Analysis of efficacy of lenvatinib treatment in highly advanced hepatocellular carcinoma with tumor thrombus in the main trunk of the portal vein or tumor with more than 50% liver occupation: A multicenter analysisMakoto Chuma, Haruki Uojima, Atsushi Hiraoka, et al.Heart (British Cardiac Society)|March 16, 2017
Arrhythmia risk and β-blocker therapy in pregnant women with long QT syndromeKohei Ishibashi, Takeshi Aiba, Chizuko Kamiya, et al.Journal of Clinical Medicine|June 6, 2020
Long-Term Prognosis of Patients with Myocardial Infarction Type 1 and Type 2 with and without Involvement of Coronary VasospasmRyota Sato, Kenji Sakamoto, Koichi Kaikita, et al.European Journal of Gastroenterology & Hepatology|July 8, 2022
Glasgow prognostic score predicts survival in patients with unresectable hepatocellular carcinoma treated with lenvatinib: a multicenter analysisToshifumi Tada, Takashi Kumada, Atsushi Hiraoka, et al.JCO Clinical Cancer Informatics|May 12, 2025
Prognostic Significance of the BALAD Serological Model in Systemic Therapies for Hepatocellular Carcinoma: A Personalized Approach to the Prediction of Survival BenefitHidenori Toyoda, Atsushi Hiraoka, Hironori Ochi, et al.Scientific Reports|May 19, 2022
C-reactive protein to albumin ratio predicts survival in patients with unresectable hepatocellular carcinoma treated with lenvatinibToshifumi Tada, Takashi Kumada, Atsushi Hiraoka, et al.Journal of Gastroenterology and Hepatology|August 19, 2023
Identification of clinical phenotypes associated with poor prognosis in patients with nonalcoholic fatty liver disease via unsupervised machine learningTakanori Ito, Hikaru Morooka, Hirokazu Takahashi, et al.Research and Practice in Thrombosis and Haemostasis|January 25, 2024
von Willebrand factor Ristocetin co-factor activity to von Willebrand factor antigen level ratio for diagnosis of acquired von Willebrand syndrome caused by aortic stenosisNoriyuki Okubo, Shingo Sugawara, Tohru Fujiwara, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|April 25, 2024
Validation study of age-independent fibrosis score (Fibrosis-3 index) in patients with metabolic dysfunction-associated steatotic liver diseaseKazuhiro Nouso, Miwa Kawanaka, Hideki Fujii, et al.International Journal of Molecular Sciences|July 17, 2020
Common Drug Pipelines for the Treatment of Diabetic Nephropathy and Hepatopathy: Can We Kill Two Birds with One Stone?Yoshio Sumida, Masashi Yoneda, Hidenori Toyoda, et al.Pageof 97